GlassScriptPhysician profile
Julie Ann Johnson
NPI 1134203805
$243.81
in general payments reported to CMS, 2019-2025
10 companies · $35.02 in 2025
The $35.02 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $95.53 · 2023: $93.88 · 2024: $19.38 · 2025: $35.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $148.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $38.97 | 2022-2023 | |
| Pfizer INC. | $34.85 | 2022-2023 | |
| Corium, LLC | $29.41 | 2023 | Adlarity |
| Galderma Laboratories, L.P. | $28.38 | 2022 | |
| Abbott Laboratories | $23.83 | 2023 | Freestyle Libre 3 |
| Pharmacosmos Therapeutics INC. | $20.96 | 2025 | Monoferric |
| Neurocrine Biosciences, INC. | $19.38 | 2024 | Ingrezza |
| Organogenesis INC. | $18.65 | 2022 | |
| Sanofi-Aventis U.S. LLC | $15.32 | 2022 | |
| Exact Sciences Corporation | $14.06 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.